Atlas Trials

A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia

Clinical trial NCT01701375 · TERMINATED

Trial details

NCT number
NCT01701375
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed Acute LeukemiaRefractory Acute LeukemiaHigh-Risk Myelodysplasia
Start date
2012-09-01
Primary completion
2013-04-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.